ClinicalTrials.gg
Not yet recruitingNCT07948148Updated Nov 19, 2026

Prediction of Post-Spinal Hypotension During Cesarean Delivery Using Machine Learning Algorithms

An observational study in Post-Spinal Hypotension, sponsored by Istinye University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Istinye University · Observational

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
250
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 96 studies in Hypotension with a site in Turkey — 34 open to participants now, 35 under way, none of them phase 3. Hypotension · Turkey.

Planned enrollment
8th of 62
250 · median 100
Started
2026
with 23 others
Observational
62 of 96
24 open now
Primary completion
2027-01
later than 26 of 34 live
Registered
96th of 96
by date

Among the 96 studies in Hypotension with a site in Turkey, this one is the 8th largest by planned enrollment of the 62 observational ones that give a count, is one of 24 that started in 2026, is one of 62 observational ones, reaches primary completion later than 26 of the 34 other live ones, and was the 96th registered.

Hypotension

893 studies on the registry are indexed under Hypotension; 197 are open to participants now.

Browse Hypotension studies →

Open to participants now

34 of the 96 studies in Hypotension with a site in Turkey are open now. Recruiting first, the newest first:

29 more — sign in →

All 34 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 112 Hypotension studies recruiting now, 51 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Hypotension with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to develop and prospectively validate machine learning models for predicting hypotension following spinal anesthesia in pregnant women undergoing elective cesarean delivery. The study consists of two cohorts: a retrospective training cohort including at least 200 patients and an independent prospective validation cohort including 50 patients.

Three machine learning algorithms (Random Forest, XGBoost, and Logistic Regression) will be trained using preoperative demographic, anthropometric, and baseline hemodynamic variables, including age, body mass index, parity, gestational age, baseline systolic blood pressure, and baseline heart rate.

The primary outcome is post-spinal hypotension, defined as a decrease in systolic blood pressure of at least 20% from baseline and/or the requirement for vasopressor administration within the first 15 minutes after spinal anesthesia.

The best-performing model will be evaluated in the independent prospective cohort to assess its predictive performance in a real clinical setting.

03

Conditions studied

  • Post-Spinal Hypotension

Browse trials for

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of pregnant women aged 18-45 years with ASA physical status I-II, singleton pregnancies, and scheduled for elective cesarean delivery under spinal anesthesia. The study will include two cohorts: a retrospective training cohort of at least 200 eligible patients identified from hospital records between January 1, 2025, and October 1, 2026, and an independent prospective validation cohort of 50 eligible pregnant women. Participants will be assessed according to predefined inclusion and exclusion criteria. The study population will include women with no history of chronic hypertension or preeclampsia/eclampsia and without contraindications to neuraxial anesthesia.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 45 years.
  • I-II.
  • Singleton pregnancy.
  • Scheduled for elective cesarean delivery under spinal anesthesia.

Exclusion criteria

Exclusion Criteria:

  • Multiple pregnancy.
  • Emergency cesarean delivery, including cases of fetal distress.
  • Chronic hypertension.
  • History of preeclampsia or eclampsia.
  • to neuraxial anesthesia.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
250 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Predictive Performance of Machine Learning Models for Post-Spinal Hypotension

    The predictive performance of machine learning models (Random Forest, XGBoost, and Logistic Regression) for identifying post-spinal hypotension will be evaluated using the area under the receiver operating characteristic curve (AUC-ROC). Post-spinal hypotension is defined as a decrease in systolic blood pressure of at least 20% from baseline and/or the requirement for vasopressor administration within the first 15 minutes following spinal anesthesia. Models will be developed using the retrospective training cohort and evaluated in the independent prospective validation cohort.

    Time frame: Within the first 15 minutes following spinal anesthesia.

07

Study locations

1 site
08

References and documents

Publications

  • Yang X, Li YM, Wang Q, Li R, Zhang P. Machine learning model based on RCA-PDCA nursing methods and differentiating factors to predict hypotension during cesarean section surgery. Comput Biol Med. 2024 May;174:108395. doi: 10.1016/j.compbiomed.2024.108395. Epub 2024 Apr 2. PubMed 38599068 ↗
  • Hung KC, Liu CC, Huang YT, Wu JY, Chen JY, Ko CC, Lin CM, Hsing CH, Yew M, Chen IW. Predictive Efficacy of the Perfusion Index for Hypotension following Spinal Anesthesia in Parturient Undergoing Elective Cesarean Section: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2023 Aug 3;13(15):2584. doi: 10.3390/diagnostics13152584. PubMed 37568947 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

Of 148 non-industry observational studies under Hypotension, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 2 months is below that.

Counting every sponsor, half of 153 studies reached it within 11 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 15, 2026
First posted
Nov 19, 2026
StartEst.
Nov 21, 2026
Primary completionEst.
Jan 21, 2027
CompletionEst.
Feb 1, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948148
Lead sponsor
Istinye University
Responsible party
İlke Dolgun (Assoc. prof, Istinye University) — Principal investigator
First posted
Nov 19, 2026
Start date
Nov 21, 2026 (estimated)
Primary completion
Jan 21, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

ilke dolğun
Contact
ilkeser2004@gmail.com
+905555485632

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion